Chartwell Investment Partners, LLC Novartis Ag Transaction History

Chartwell Investment Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 30, 2020	SELL	$70.67 - $99.01 $1.66 Million - $2.32 Million	-23,439 Closed	0 $0
Q4 2019 Jan 29, 2020	SELL	$84.35 - $95.37 $688,802 - $778,791	-8,166 Reduced 25.84%	23,439 $2.22 Million
Q3 2019 Oct 29, 2019	SELL	$85.54 - $94.26 $387,325 - $426,809	-4,528 Reduced 12.53%	31,605 $2.75 Million
Q2 2019 Aug 19, 2019	BUY	$75.4 - $92.8 $313,588 - $385,955	4,159 Added 13.01%	36,133 $3.3 Million
Q1 2019 Apr 11, 2019	SELL	$75.32 - $86.15 $92,417 - $105,706	-1,227 Reduced 3.7%	31,974 $3.07 Million
Q4 2018 Feb 01, 2019	BUY	$73.66 - $82.02 $213,908 - $238,186	2,904 Added 9.59%	33,201 $2.85 Million
Q3 2018 Nov 08, 2018	BUY	$66.94 - $77.43 $1.61 Million - $1.86 Million	24,007 Added 381.67%	30,297 $2.61 Million
Q2 2018 Aug 09, 2018	BUY	$64.91 - $73.36 $408,283 - $461,434	6,290 New	6,290 $475,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Chartwell Investment Partners, LLC with notifications on news.